Advertisement
QIAGEN Ingenuity
QIAGEN Ingenuity

The Scientist

» drug development, culture and ecology

Most Recent

image: Polypharmacy

Polypharmacy

By | July 1, 2012

Dietary supplements can have serious side effects when mixed with prescription drugs, but not all herb-drug interactions are bad.

14 Comments

image: The Little Cell That Could

The Little Cell That Could

By | July 1, 2012

Critics point out that cell therapy has yet to top existing treatments. Biotech companies are setting out to change that—and prove that the technology can revolutionize medicine.

1 Comment

image: Flower Barcodes

Flower Barcodes

By | June 28, 2012

Wales creates a database of DNA barcodes for all of its native flowering plants, hoping to guide conservation and drug development efforts.

1 Comment

image: EPA to Regulate Greenhouse Emissions

EPA to Regulate Greenhouse Emissions

By | June 28, 2012

A federal appeals court upholds the Environmental Protection Agency’s right to regulate air pollution under the Clean Air Act.

1 Comment

image: Mixed Report for Oiled Salt Marshes

Mixed Report for Oiled Salt Marshes

By | June 25, 2012

Louisiana’s salt marshes are recovering from the Deepwater Horizon oil spill, but some areas have been irreversibly lost.

3 Comments

image: NIH Tackles Racism

NIH Tackles Racism

By | June 25, 2012

An advisory committee urges the federal funding agency to take steps to counter racial bias in the granting process.

2 Comments

image: The Gigapixel Camera

The Gigapixel Camera

By | June 22, 2012

A single camera unit can capture a moment in time at a mind-boggling resolution.

1 Comment

image: “Extinct” Toad Rediscovered

“Extinct” Toad Rediscovered

By | June 21, 2012

A yellow-bellied dwarf toad, last sighted in 1876, is rediscovered in Sri Lanka.

0 Comments

image: A Plea to the FDA

A Plea to the FDA

By | June 21, 2012

Protesters crash the BIO conference to protest the delayed approval of a breast cancer drug.

2 Comments

image: New FDA Review Process Debated

New FDA Review Process Debated

By | June 20, 2012

Industry experts discuss the agency’s plans to make the drug approval process more transparent.

0 Comments

Advertisement

Popular Now

  1. First Data from Anti-Aging Gene Therapy
  2. The Two Faces of Fish Oil
    Notebook The Two Faces of Fish Oil

    The discovery of a tumor-protecting role for a fatty acid found in fish oil has sparked debate about the product’s safety.

  3. The Zombie Literature
    Features The Zombie Literature

    Retractions are on the rise. But reams of flawed research papers persist in the scientific literature. Is it time to change the way papers are published?

  4. Locating Language within the Brain
Advertisement
Gilson
Gilson
Advertisement
RayBioTech